Mednet Logo
CommunityRheumatology

How do you approach management in patients with adult-onset Still’s disease presenting with active polyarthritis (without macrophage activation syndrome) who remain symptomatic despite prednisone 15 mg/day and methotrexate 25 mg/week?

What biologic therapy do you consider next?
Community PollStarted

What biologic therapy do you consider next in a patient with adult-onset Still’s disease presenting with active polyarthritis who remains symptomatic despite prednisone 15 mg/day and methotrexate 25 mg/week?

85 physicians have voted

Join Mednetto vote and see how they answered.

1 Answer
Mednet Member
Mednet MemberInvited Expert
Rheumatology · Massachusetts General Hospital
Answered on · Updated on

Biologics, especially IL-1 but also IL-6 blockers, have been shown to be beneficial for patients with Still's disease. In fact, there seems to be a window of opportunity whereby patients that are started early on cytokine blockade are more likely to achieve drug-free remission in the future. Anakinr...

Join for free or sign in to see the full answer